TAK · Takeda Pharmaceutical Co Ltd
Market Cap
$58.66B
Shares
3.19B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-31 | 2026-08-28 | |
| 6-K | 2026-08-06 | 2026-08-05 | |
| 6-K | 2026-07-30 | — | |
| 6-K | 2026-07-09 | — | |
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-06-29 | — | |
| 6-K | 2026-06-26 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-24 | — | |
| 6-K | 2026-06-24 | — | |
| 20-F | 2026-06-17 | 2026-03-31 | |
| 6-K | 2026-06-09 | — | |
| 6-K | 2026-06-05 | — | |
| 6-K | 2026-06-05 | — | |
| 6-K | 2026-06-01 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-26 | — | |
| 6-K | 2026-05-19 | — | |
| 6-K | 2026-05-13 | — | |
| 6-K | 2026-05-13 | — | |
| 6-K | 2026-03-30 | — | |
| 6-K | 2026-03-26 | — | |
| 6-K | 2026-03-25 | — | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-02-10 | — | |
| 6-K | 2026-01-29 | — | |
| 6-K | 2025-12-18 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-11-28 | — | |
| 6-K | 2025-10-30 | — | |
| 6-K | 2025-10-30 | — | |
| 6-K | 2025-10-30 | — | |
| 6-K | 2025-10-01 | — | |
| 6-K | 2025-09-25 | — | |
| 6-K | 2025-09-08 | — | |
| 6-K | 2025-07-31 | — | |
| 6-K | 2025-07-30 | — | |
| 6-K | 2025-07-14 | — | |
| 6-K | 2025-07-09 | — | |
| 6-K | 2025-07-08 | — | |
| 6-K | 2025-07-02 | — | |
| 6-K | 2025-07-01 | — | |
| 6-K | 2025-06-30 | — | |
| 6-K | 2025-06-25 | — | |
| 20-F | 2025-06-25 | 2025-03-31 | |
| 6-K | 2025-06-25 | — | |
| 6-K | 2025-06-12 | — |
Showing 1–50 of 310 filings